NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $26.86 +0.01 (+0.04%) Closing price 04:00 PM EasternExtended Trading$26.86 0.00 (0.00%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About National Research Stock (NASDAQ:NRC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get National Research alerts:Sign Up Key Stats Today's Range$26.49▼$27.1550-Day Range$19.57▼$27.0752-Week Range$11.73▼$27.41Volume125,981 shsAverage Volume112,493 shsMarket Capitalization$611.07 millionP/E Ratio95.93Dividend Yield2.38%Price Target$27.00Consensus RatingHold Company Overview National Research Corporation, which operates as NRC Health, provides experience-management and consumer-insights services to organizations in the health care industry. Its research and technology help clients understand how patients, health care consumers and employees perceive their services. The company’s offerings include patient and consumer surveys, employee-engagement research, reputation measurement, analytics and related advisory services. Hospitals, health systems and other health care organizations use these tools to identify opportunities to improve service and strengthen relationships with the communities they serve. Founded in 1981 and headquartered in Lincoln, Nebraska, NRC Health serves health care organizations primarily in the United States. Its work focuses on collecting and interpreting feedback and turning those insights into practical guidance for clients.AI Generated. May Contain Errors. Read More National Research Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreNRC MarketRank™: 2.205420267085 of 5 starsNational Research scored higher than 44% of companies evaluated by MarketBeat, and ranked 625th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.8 / 5Analyst RatingHold Consensus RatingNational Research has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for National Research is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageNational Research has only been the subject of 3 research reports in the past 90 days.Read more about National Research's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth9.28% Earnings GrowthEarnings for National Research are expected to grow by 9.28% in the coming year, from $0.97 to $1.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 95.93, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.19.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 95.93, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.36. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.33% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in National Research has recently decreased by 5.34%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldNational Research pays a meaningful dividend of 2.38%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 228.57%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, National Research will have a dividend payout ratio of 60.38% next year. This indicates that National Research will be able to sustain or increase its dividend.Read more about National Research's dividend. News and Social Media2.2 / 5News Sentiment0.55 News SentimentNational Research has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for National Research this week, compared to 1 article on an average week. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by Insiders9.20% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about National Research's insider trading history. Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRC Stock News HeadlinesNRC Health: 3 Key Takeaways for Long-Term InvestorsNovember 8 at 6:15 PM | fool.comNational Research (NASDAQ:NRC) Upgraded to Buy at Wall Street ZenNovember 7, 2026 | americanbankingnews.comUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.November 11 at 1:00 AM | Digest Publishing (Ad)FY2026 EPS Forecast for National Research Reduced by AnalystNovember 2, 2026 | americanbankingnews.comNational Research (NASDAQ:NRC) Shares Gap Up After Analyst UpgradeOctober 31, 2026 | americanbankingnews.comNRC Health Declares Quarterly Cash Dividend, Payable on January 8, 2027October 28, 2026 | marketscreener.comMNRC Health Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026October 27, 2026 | marketscreener.comMNational Research Corporation reports third quarter 2026 revenue of $38.4 millionOctober 27, 2026 | msn.comSee More Headlines NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $18.77 at the beginning of the year. Since then, NRC stock has increased by 43.1% and is now trading at $26.86. How were National Research's earnings last quarter? National Research Corporation (NASDAQ:NRC) issued its earnings results on Tuesday, October, 27th. The company reported $0.21 EPS for the quarter, topping analysts' consensus estimates of $0.18 by $0.03. The firm had revenue of $38.40 million for the quarter, compared to the consensus estimate of $35.80 million. National Research had a trailing twelve-month return on equity of 313.25% and a net margin of 4.48%. Read the conference call transcript. Does National Research have any subsidiaries? The following companies are subsidiaries of National Research: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. Who are National Research's major shareholders? Top institutional investors of National Research include Farmers & Merchants Investments Inc. (2.21%), Willis Investment Counsel (1.89%), Fifth Third Bancorp (0.37%) and Russell Investments Group Ltd. (0.17%). Insiders that own company stock include Amandla Mk Trust, Patrick E Beans and Jordan Nicole Freeman. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Marvell Technology (MRVL), Micron Technology (MU), Cronos Group (CRON), Cisco Systems (CSCO), First Majestic Silver (AG), Arista Networks (ANET) and Applied Materials (AMAT). Company Calendar Record date for 10/9 Dividend9/25/2026Ex-Dividend for 10/9 Dividend9/25/2026Dividend Payable10/09/2026Last Earnings10/27/2026Today11/11/2026Record date for 1/8 Dividend12/29/2026Ex-Dividend for 1/8 Dividend12/29/2026Fiscal Year End12/31/2026Dividend Payable1/08/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (8m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 NRC's financial health is in the Green zone, according to TradeSmith. NRC has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:NRC CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees357Year Founded1981Price Target and Rating Average Price Target for National Research$27.00 High Price Target$27.00 Low Price Target$27.00 Potential Upside/Downside+0.5%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.28 Trailing P/E Ratio95.93 Forward P/E Ratio25.34 P/E GrowthN/ANet Income$11.60 million Net Margins4.48% Pretax Margin7.31% Return on Equity313.25% Return on Assets14.32% Debt Debt-to-Equity Ratio13.13 Current Ratio0.64 Quick Ratio0.64 Sales & Book Value Annual Sales$137.39 million Price / Sales4.45 Cash Flow$1.26 per share Price / Cash Flow21.35 Book Value($0.40) per share Price / Book-67.15Miscellaneous Outstanding Shares22,750,000Free Float20,653,000Market Cap$611.07 million OptionableOptionable Beta0.22 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:NRC) was last updated on 11/11/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | SponsoredThis 10.3% war bond closed once. It's finally open again.Todd Phillips has spent 30 years studying safe-money income. His test for real retirement income: can it promi...Eagle Publishing | SponsoredImportant: Mission X AlertA company operating in the shadows with SpaceX is about to step into the light. Its CEO told employees he will...StocksToTrade | SponsoredFormer White House Insider Issues Crazy Prediction: Dow 100,000Jim Rickards just issued a new 2027 prediction: Dow 100,000. He has advised members of President Trump's cabin...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRC Stock Alerts